Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2
Approvals & regulatory · first seen 10h ago, updated 10h ago

GRAIL sets new 52-week high as FDA panel backs cancer test

1 outlet FDA

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    GRAIL sets new 52-week high as FDA panel backs cancer test